DUBLIN, July 22, 2014 /PRNewswire/ -- Jazz
Pharmaceuticals plc (Nasdaq: JAZZ) today announced that it will
report its 2014 second quarter financial results on Tuesday, August 5, 2014, after the close of the
financial markets. Company management will host a live audio
webcast immediately following the announcement at 4:30 p.m. EDT/9:30 p.m.
IST to provide a business and financial update and discuss
second quarter 2014 financial results.
Interested parties may access the live audio webcast via the
Investors & Media section of the Jazz Pharmaceuticals website
at www.jazzpharmaceuticals.com. Please connect to the website prior
to the start of the conference call to ensure adequate time for any
software downloads that may be necessary to listen to the webcast.
A replay of the webcast will be archived on the website for one
week.
Audio webcast/conference call:
U.S. Dial-In Number:
+1-866-277-1184
International Dial-In Number: +1-617-597-5360
Passcode: 29980973
A replay of the conference call will be available through
August 12, 2014 and accessible
through one of the following telephone numbers and entering the
passcode:
Replay U.S. Dial-In Number: +1-888-286-8010
Replay International Dial-In Number: +1-617-801-6888
Passcode: 13741471
About Jazz Pharmaceuticals
Jazz Pharmaceuticals plc is a specialty biopharmaceutical
company focused on improving patients' lives by identifying,
developing and commercializing differentiated products that address
unmet medical needs. The company has a diverse portfolio of
products and/or product candidates in the areas of sleep,
hematology/oncology, pain and psychiatry. The company's U.S.
marketed products in these areas include: Xyrem® (sodium oxybate)
oral solution, Erwinaze® (asparaginase Erwinia
chrysanthemi), Prialt® (ziconotide) intrathecal infusion,
Versacloz® (clozapine) oral suspension, FazaClo® (clozapine, USP)
HD and FazaClo LD. Jazz Pharmaceuticals also has a number of
products marketed outside the U.S., including Erwinase® and
Defitelio® (defibrotide). For more information, please visit
www.jazzpharmaceuticals.com.